News

Published on 18 Jun 2024 on Insider Monkey · via Yahoo Finance

Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy...

Article preview image

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this article, we are going to take a look at where Arvinas, Inc. (NASDAQ:ARVN) stands against the other small-cap stocks.

Small-cap stocks are companies with a market capitalization of somewhere between $250 million and $2 billion. They are usually the new and the world’s up-and-coming companies.

Read the rest of the article
NASDAQ.ARVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode

We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we...

Insider Monkey · via Yahoo Finance 19 Nov 2024
Arvinas Inc (ARVN) Q3 2024: Everything You Need To Know Ahead Of Earnings

Arvinas Inc (NASDAQ:ARVN) is set to release its Q3 2024 earnings on Oct 30, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 29 Oct 2024
Arvinas (ARVN): A Small-Cap Biotech with High Growth Potential

We recently published a list of 8 Best Small-Cap Growth Stocks to Buy According to Analysts. In t...

Insider Monkey · via Yahoo Finance 23 Oct 2024
Arvinas, Inc. (ARVN): This Small-Cap Healthcare Stock Is A Good Buy Right Now

We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this articl...

Insider Monkey · via Yahoo Finance 19 Sep 2024
Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy...

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 18 Jun 2024
Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Arvinas, Inc. (ARVN) is expected to deliver a year-over-year increase in earnings on higher reven...

Zacks via Yahoo Finance 26 Apr 2024
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...

Zacks via Yahoo Finance 12 Apr 2024
H.C. Wainwright lowers Arvinas shares target amid Novartis licensing deal for ARV-766

H.C. Wainwright lowers Arvinas shares target amid Novartis licensing deal for ARV-766

Investing.com 11 Apr 2024
Stifel lifts Arvinas shares PT on ARV-766 sales forecast update By Investing.com

On Thursday, Stifel maintained a Buy rating on Arvinas Inc. (NASDAQ:ARVN) and increased the price...

Investing.com 11 Apr 2024
Arvinas inks over $1.0 billion deal with Novartis

Arvinas Inc (NASDAQ: ARVN) is in the green at writing after announcing a deal worth over $1.0 bil...

Invezz 11 Apr 2024

Copyright Statfolio @ 2024

Social Accounts